Form 8-K - Current report:
SEC Accession No. 0001404644-25-000049
Filing Date
2025-06-09
Accepted
2025-06-09 07:25:28
Documents
56
Period of Report
2025-06-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ngne-20250609.htm   iXBRL 8-K 26222
2 EX-99.1 a202506_ngnecorporatepre.htm EX-99.1 49616
6 a202506_ngnecorporatepre001.jpg GRAPHIC 103634
7 a202506_ngnecorporatepre002.jpg GRAPHIC 274023
8 a202506_ngnecorporatepre003.jpg GRAPHIC 98890
9 a202506_ngnecorporatepre004.jpg GRAPHIC 59498
10 a202506_ngnecorporatepre005.jpg GRAPHIC 130437
11 a202506_ngnecorporatepre006.jpg GRAPHIC 37699
12 a202506_ngnecorporatepre007.jpg GRAPHIC 120012
13 a202506_ngnecorporatepre008.jpg GRAPHIC 116212
14 a202506_ngnecorporatepre009.jpg GRAPHIC 86436
15 a202506_ngnecorporatepre010.jpg GRAPHIC 83362
16 a202506_ngnecorporatepre011.jpg GRAPHIC 83434
17 a202506_ngnecorporatepre012.jpg GRAPHIC 78052
18 a202506_ngnecorporatepre013.jpg GRAPHIC 103852
19 a202506_ngnecorporatepre014.jpg GRAPHIC 137289
20 a202506_ngnecorporatepre015.jpg GRAPHIC 91446
21 a202506_ngnecorporatepre016.jpg GRAPHIC 117766
22 a202506_ngnecorporatepre017.jpg GRAPHIC 101522
23 a202506_ngnecorporatepre018.jpg GRAPHIC 92531
24 a202506_ngnecorporatepre019.jpg GRAPHIC 115575
25 a202506_ngnecorporatepre020.jpg GRAPHIC 80701
26 a202506_ngnecorporatepre021.jpg GRAPHIC 136559
27 a202506_ngnecorporatepre022.jpg GRAPHIC 30071
28 a202506_ngnecorporatepre023.jpg GRAPHIC 89937
29 a202506_ngnecorporatepre024.jpg GRAPHIC 145703
30 a202506_ngnecorporatepre025.jpg GRAPHIC 129495
31 a202506_ngnecorporatepre026.jpg GRAPHIC 118605
32 a202506_ngnecorporatepre027.jpg GRAPHIC 122967
33 a202506_ngnecorporatepre028.jpg GRAPHIC 112414
34 a202506_ngnecorporatepre029.jpg GRAPHIC 100900
35 a202506_ngnecorporatepre030.jpg GRAPHIC 75708
36 a202506_ngnecorporatepre031.jpg GRAPHIC 100833
37 a202506_ngnecorporatepre032.jpg GRAPHIC 75229
38 a202506_ngnecorporatepre033.jpg GRAPHIC 119907
39 a202506_ngnecorporatepre034.jpg GRAPHIC 37193
40 a202506_ngnecorporatepre035.jpg GRAPHIC 61623
41 a202506_ngnecorporatepre036.jpg GRAPHIC 30285
42 a202506_ngnecorporatepre037.jpg GRAPHIC 135606
43 a202506_ngnecorporatepre038.jpg GRAPHIC 143304
44 a202506_ngnecorporatepre039.jpg GRAPHIC 134795
45 a202506_ngnecorporatepre040.jpg GRAPHIC 120510
46 a202506_ngnecorporatepre041.jpg GRAPHIC 90271
47 a202506_ngnecorporatepre042.jpg GRAPHIC 90589
48 a202506_ngnecorporatepre043.jpg GRAPHIC 82808
  Complete submission text file 0001404644-25-000049.txt   6273957

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngne-20250609.xsd EX-101.SCH 1788
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngne-20250609_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngne-20250609_pre.xml EX-101.PRE 13050
58 EXTRACTED XBRL INSTANCE DOCUMENT ngne-20250609_htm.xml XML 2802
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Filer) CIK: 0001404644 (see all company filings)

EIN.: 980542593 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36327 | Film No.: 251032835
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)